This inventor holds 4 USPTO granted patents and 10 published patent applications, plus 1 CIPO patent and 1 EPO patent. Top assignees: Surrozen Operating, Inc., Leland Stanford Junior University, University of Washington. Active years: 2021-2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Palo Alto, CA (US) (2021 - 2023)
- South San Francisco, CA (US) (2024)
Company Filing History:
3 out of 8 
1 out of 5,515 
1 out of 2,173 
Years Active: 2021-2025
Title: Claudia Yvonne Janda: Innovator in Therapeutic Solutions
Introduction
Claudia Yvonne Janda is a prominent inventor based in Palo Alto, CA. She has made significant contributions to the field of therapeutic innovations, holding a total of 4 patents. Her work focuses on developing novel solutions for various diseases, particularly through the modulation of the Wnt signaling pathway.
Latest Patents
Among her latest patents, Janda has developed "Wnt surrogate molecules and uses thereof." This invention provides Wnt pathway agonists and related compositions that can be utilized in various therapeutic methods for treating diseases. Another notable patent is "Anti-frizzled antibodies and methods of use," which offers anti-Fzd monoclonal antibodies and related compositions for therapeutic applications.
Career Highlights
Throughout her career, Claudia has worked with notable organizations, including Surrozen Operating, Inc. and Leland Stanford Junior University. Her innovative research has positioned her as a key figure in the development of therapeutic agents targeting the Wnt pathway.
Collaborations
Claudia has collaborated with esteemed colleagues such as Yang Li and Tom Zhiye Yuan, contributing to the advancement of her research and the development of her patents.
Conclusion
Claudia Yvonne Janda's work exemplifies the impact of innovative thinking in the field of therapeutics. Her patents and collaborations highlight her commitment to advancing medical science and improving treatment options for various diseases.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile